https://tickerspark.ai/market/summit-therapeutics-inc-smmt-drops-9-9-on-profit-taking-1776877577682
Summit Therapeutics Inc. (SMMT) drops 9.9% on profit-taking | TickerSpark
Apr 22, 2026 - Summit Therapeutics Inc. (SMMT) drops 9.9% today on profit-taking and no fresh catalyst, as high short interest fuels volatility ahead of ivonescimab updates.
summit therapeuticsprofit takingincsmmtdrops
https://www.fiercebiotech.com/keyword/summit-therapeutics
Summit Therapeutics | Fierce Biotech
summit therapeuticsfiercebiotech
https://pro.thestreet.com/thefly-newsbreaks/smmt-summit-therapeutics-price-target-raised-by-at-stifel-heres-why
Summit Therapeutics price target raised by $6 at Stifel, here's why | TheStreet Pro
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's...
summit therapeuticsprice targetraisedstifelthestreet
https://de.marketscreener.com/kurs/aktie/SUMMIT-THERAPEUTICS-INC-21452860/news/Transcript-Summit-Therapeutics-Inc-Q1-2024-Earnings-Call-May-01-2024-46594728/
Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 | MarketScreener...
summit therapeuticsearnings calltranscriptincmay
https://altindex.com/ticker/smmt/twitter-followers
Summit Therapeutics (SMMT) X Followers Statistics 2026
Analyze X Followers for Summit Therapeutics and gain a competitive edge with unique and comprehensive information.
summit therapeuticsx followerssmmtstatistics
https://biohired.com/jobs/98257
IT Business Analyst - G&A at Summit Therapeutics in Palo Alto, CA (US) | Biohired
it business analystpalo alto caat summitgtherapeutics
https://www.edgen.tech/news/post/summit-therapeutics-stock-drops-25-after-cancer-drug-setback
Summit Therapeutics stock drops 25% after cancer drug setback
Summit Therapeutics (SMMT) stock fell sharply after an interim analysis of its lead cancer drug, ivonescimab, failed to meet an early endpoint, overshadowing a...
summit therapeuticsafter cancerstockdropsdrug
https://www.itiger.com/news/2616433901
H.C. Wainwright Sticks to Its Buy Rating for Summit Therapeutics (SMMT) - Tiger Brokers
H.C. Wainwright Sticks to Its Buy Rating for Summit Therapeutics (SMMT). On Tiger Brokers' website to stay informed on market trends, price movements, and...
summit therapeuticstiger brokerswainwrightsticksbuy
https://www.fool.com/investing/2025/07/03/why-summit-therapeutics-stock-soared-8-higher-toda/
Why Summit Therapeutics Stock Soared 8% Higher Today | The Motley Fool
Jul 3, 2025 - Why Summit Therapeutics Stock Soared 8% Higher Today
the motley foolwhy summittherapeuticsstocksoared
https://www.home.saxo/fr-fr/markets/stocks/smmt-xnas
Summit Therapeutics Plc action | Saxo Banque
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious...
summit therapeuticssaxo banqueplcaction
https://ch2report.com/company/cmp__a_ed2qssrngdavkturho
Summit Therapeutics Inc. | Chat2Report - Your AI Assistant for Financial Reports | Chat2Report
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal...
ai assistant forsummit therapeuticsfinancial reportsinc
https://www.panabee.com/news/summit-therapeutics-validates-bispecific-strategy-with-40-risk-reduction-in-head-to-head
Summit Therapeutics Validates Bispecific Strategy with 40% Risk Reduction in Head-to-Head Lung...
Summit Therapeutics announced strong clinical validation for its lead bispecific antibody, ivonescimab, which demonstrated a 40% reduction in disease...
summit therapeuticsrisk reductionbispecificstrategyhead
https://pages.m1.com/invest/stocks/SMMT
Summit Therapeutics Inc. - SMMT Stock Price Quote & News - M1
Start with SMMT and build your long-term investing strategy with M1. Buy or sell stocks and ETFs commission free.
summit therapeuticsstock priceincsmmtquote
https://www.bioworld.com/articles/719717-summit-therapeutics-describes-new-kras-g12d-inhibitors-and-degradation-inducers?v=preview
Summit Therapeutics describes new KRAS (G12D) inhibitors and degradation inducers | BioWorld
Summit Therapeutics Inc. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety coupled to a GTPase...
summit therapeuticsdescribesnewkrasinhibitors
https://public.com/stocks/smmt/pre-market
Trade Summit Therapeutics (SMMT) Stock Pre-Market on Public.com
Trade Summit Therapeutics (SMMT) stock in the pre-market on Public.com from 4:00 AM to 9:30 AM ET. Track SMMT price, range, and movement before the market...
summit therapeuticspre marketpublic comtradesmmt
https://www.trade-ideas.com/ticky/ticky.html?symbol=SMMT
Summit Therapeutics Inc (SMMT) Stock Analysis Buy and Sell Signals and News | Trade-Ideas
buy and sellsummit therapeuticsstock analysistrade ideasinc
https://stockti.com/summit-therapeutics-shares-dive-23-after-harmoni-3-update-disappoints
Summit Therapeutics Shares Dive 23% After HARMONi-3 Update Disappoints | StockTi
May 13, 2026 - Summit Therapeutics (SMMT) shares fell 23% after an interim HARMONi-3 trial update for ivonescimab showed no early benefit. Final PFS data expected in
summit therapeuticssharesdiveharmoniupdate
https://pharma.economictimes.indiatimes.com/news/pharma-industry/astrazeneca-and-summit-therapeutics-explore-15-billion-cancer-drug-deal/122238601
AstraZeneca Cancer Drug Licensing Deal: AstraZeneca and Summit Therapeutics Explore $15 Billion...
AstraZeneca Cancer Drug Licensing Deal: AstraZeneca is negotiating with Summit Therapeutics for a potential licensing agreement valued at $15 billion for the...
summit therapeuticsastrazenecacancerdruglicensing
https://carb-x.org/carb-x-news/summit-therapeutics-nominates-carb-x-funded-smt-571-as-lead-clinical-candidate-for-treatment-of-gonorrhoea/
Summit Therapeutics nominates CARB-X-funded SMT-571 as lead clinical candidate for treatment of...
summit therapeuticscarbxfundedsmt
https://www.biotechtv.com/all-videos/tags/summit-therapeutics
Summit Therapeutics | BiotechTV
summit therapeutics
https://www.hl.co.uk/shares/shares-search-results/s/summit-therapeutics-inc-usd0.01
Summit Therapeutics Inc USD0.01 share price | SMMT
The latest Summit Therapeutics Inc USD0.01 share price (SMMT). View recent trades and share price information for Summit Therapeutics Inc USD0.01.
summit therapeuticsshare priceincsmmt
https://www.resumemate.io/jobs/account-director-remote-jobs/7e7a1e_summittherapeutics_4195442009
Corporate Account Director, GPO at Summit Therapeutics | ResumeMate
Apply for Corporate Account Director, GPO at Summit Therapeutics in Remote (US). Skills: GPO, Market Access, Oncology Reimbursement. Apply now on ResumeMate.
corporate accountsummit therapeuticsdirectorgpo
https://himsstv.brightcovegallery.com/detail/videos/digital-therapeutics-alliance-summit-2024/video/6354711379112/dta-directtrust-highlights-newly-formed-partnership?autoStart=true
DTA, DirectTrust highlights newly formed partnership - Digital Therapeutics Alliance Summit 2024 -...
Scott Stuewe, president and CEO of DirectTrust, and Andy Molnar, CEO of the Digital Therapeutics Alliance, highlight the partners' efforts to move digital...
digital therapeuticsalliance summitdtahighlightsnewly